Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma-Reference-Cited by-同舟云学术

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma

Published:2018-03-02 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Da Gama Duarte Jessica,Parakh Sagun,Andrews Miles C.,Woods Katherine,Pasam Anupama,Tutuka Candani,Ostrouska Simone,Blackburn Jonathan M.,Behren Andreas,Cebon Jonathan

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Targeted agents and immunotherapies: optimizing outcomes in melanoma;Luke;Nat Rev Clin Oncol,2017

2. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015

3. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma;Sanderson;J Clin Oncol,2005

4. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

5. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral nervous system immune-related adverse events due to checkpoint inhibition;Nature Reviews Neurology;2024-08-09

2. Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT);Journal of Experimental & Clinical Cancer Research;2023-10-21

3. Endocrine immune-related adverse effects of immune-checkpoint inhibitors;Expert Review of Endocrinology & Metabolism;2023-09-03

4. Role of B cells in immune‐related adverse events following checkpoint blockade;Immunological Reviews;2023-07-08

5. Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors;Immuno-Oncology and Technology;2023-03